Status:
COMPLETED
Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their Caregivers
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial studies the feasibility of two positive activities in improving quality of life in collectivist culture cancer patients and their caregivers. Cancer patients of collectivist cultur...
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate the feasibility of conducting a study of two positive activities intended to improve the psychological and interpersonal well-being of cancer patients from collectiv...
Eligibility Criteria
Inclusion
- PATIENTS: Between 35 -70 years of age
- PATIENTS: Within 1-5 years of diagnosis and actively undergoing systemic therapy, including chemotherapy, immunotherapy, endocrine and radiation therapies
- PATIENTS: Self-identify as ethnically one of the 4 ethnic groups of focus: Asian American, African American, Latino, and European American. For collectivist cultures, will aim to recruit patients of who are first- (i.e., immigrated to United States \[US\]) or second-generation (i.e., children of US residents who immigrated to US) immigrants
- PATIENTS: Diagnosed with any type of cancer
- PATIENTS: Able to identify a caregiver (e.g., family member) who lives in the same household, and who consents to participate in this study
- PATIENTS: Able to read, write, and speak in English
- PATIENTS: Access to internet, computer or phone, and web browser
- CAREGIVERS: Patient considers them as their caregiver
- CAREGIVERS: Lives in the same household as patient
- CAREGIVERS: Able to read, write, and speak in English
- CAREGIVERS: Access to internet, computer or phone, and web browser
- CAREGIVERS: Identifies as the same race/ethnicity group as the patient (e.g., European American wife and European American husband, or Asian American wife and Asian American husband would be pairs that are considered eligible)
Exclusion
- PATIENTS: Life expectancy less than 6 months in the opinion of the primary physician
- PATIENTS: Inability to stand and walk on their own or with other physical limitations that preclude them from participating. (3+ on Eastern Cooperative Oncology Group \[ECOG\] performance status)
- PATIENTS: Major depression (e.g., as determined by a score of 10 or higher on the 10-item Center for Epidemiologic Studies Depression Scale \[CES-D\] at baseline, out of 30) or diagnosed prior to study (from patient records and/or self-disclosure by patient)
- CAREGIVERS: Unwilling or unable to participate in the study for any reason
- CAREGIVERS: Under the age of 18
Key Trial Info
Start Date :
May 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 19 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04810052
Start Date
May 18 2021
End Date
September 19 2025
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030